NCT04053036 Effects of Drugs on Responses to Brain and Emotional Processes Status COMPLETED Phase EARLY_PHASE1
NCT03752918 The Effects of MDMA on Prefrontal and Amygdala Activation in PTSD. Status WITHDRAWN Phase PHASE1
NCT03527316 Effect of Methylenedioxymethamphetamine (MDMA) (Serotonin Release) on Fear Extinction Status COMPLETED Phase EARLY_PHASE1
NCT03019822 Role of Dopamine, Serotonin and 5-HT2A Receptors in Emotion Processing Status COMPLETED Phase EARLY_PHASE1
NCT02876172 MDMA-Assisted Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads in Which 1 Member Has Chronic PTSD Status COMPLETED Phase PHASE1/PHASE2
NCT01951508 Effects of Methylphenidate, Modafinil, and MDMA on Emotion-processing in Humans: A Pharmaco-fMRI Study Status COMPLETED Phase EARLY_PHASE1
NCT01447472 -Methylenedioxymethamphetamine (MDMA, Ecstasy) Induced Changes in Drug Metabolism: Gender and Genetic Polymorphisms Status COMPLETED Phase PHASE1
NCT01148342 Neurobiology and Pharmacokinets of Acute MDMA Administration Status COMPLETED Phase PHASE1
NCT00895804 Pharmacological Interaction Between Pindolol and MDMA (3,4-Methylenedioxymethamphetamine) Status COMPLETED Phase PHASE1
NCT00886886 Interaction Between Reboxetine and 3,4-Methylenedioxymethamphetamine: Pharmacodynamics (PD) and Pharmacokinetics (PK) Status COMPLETED Phase PHASE1